ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: John Tamps New ACR President; Stanley Order ASTRO President Elect; Cairoli Heads Training

December 11, 1987

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.

October 21, 2005

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

Senate Passes Non-Binding Resolution To Double NIH Budget Over Five Years

May 23, 1997